COPD Set to Reach About 600 Million Cases Worldwide by 2050
By Elana Gotkine HealthDay Reporter
MONDAY, Dec. 11, 2023 -- The prevalence of chronic obstructive pulmonary disease (COPD) is projected to continue increasing through 2050, approaching 600 million patients with COPD globally by 2050, according to a study published online Dec. 7 in JAMA Network Open.
Elroy Boers, Ph.D., from ResMed Science Center in Halifax, Nova Scotia, Canada, and colleagues conducted a modeling study to examine the global burden of COPD through 2050 considering COPD risk factors. Generalized additive models were developed, which included smoking prevalence, indoor and outdoor air pollution, and development indices as predictors to project global COPD prevalence.
The researchers estimate that from 2020 to 2050, the number of COPD cases will increase by 23 percent globally among those aged 25 years and older, approaching 600 million patients with COPD globally by 2050. The growth in COPD burden was projected to be largest among women and in low- and middle-income regions. By 2050, the number of cases in women was projected to increase by 47.1 percent compared with a 9.4 percent increase in men, and the number of cases in low- and middle-income regions was projected to be more than double that of high-income regions.
"Further research, prevention, and advocacy is needed to address these issues so that adequate preparation and resource allocation can take place," the authors write.
Several authors disclosed ties to ResMed, which funded the study.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted December 2023
Read this next
AI-Assisted Contours Superior to Cognitively Defined Prostate Cancer Contours
WEDNESDAY, July 3, 2024 -- Artificial intelligence (AI)-assisted definition of prostate cancer contours reduces underestimation of the extent of prostate cancer, according to a...
Mean Cost of Bringing New Drug to U.S. Market Is $879.3 Million
TUESDAY, July 2, 2024 -- The mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when both drug development failure and capital costs are...
Patient–Primary Care Provider Language Concordance Tied to Better Outcomes
TUESDAY, July 2, 2024 -- Patient-family physician language concordance is associated with a lower risk for adverse outcomes, according to a study published online June 3...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.